Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIFAMPIN vs RILMENIDINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RIFAMPIN vs RILMENIDINE: Safety Overview

Metric RIFAMPIN RILMENIDINE
Total FAERS Reports 13,347 899
Deaths Reported 1,439 103
Death Rate 10.8% 11.5%
Hospitalizations 5,764 536
Average Patient Age 51.7 yrs 73.4 yrs
% Female Patients 47.8% 65.3%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer Hikma Pharmaceuticals USA Inc. N/A
Route INTRAVENOUS N/A
Marketing Status Discontinued N/A